Showing results (101-110 of 259) with videos related to

Sort By:
Pageof 26
Frontiers in Medicine|June 29, 2026
Disease characteristics, treatment, and outcomes in Chinese chronic lymphocytic leukemia patients following BTK inhibitor discontinuation: a multicenter real-world studyYuting Yan, Wei Wang, Xiaojing Yan, et al.
Leukemia Research|May 16, 2015
Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myelomaFei Li, Mu Hao, Xiaoyan Feng, et al.
Future Oncology (London, England)|March 25, 2020
ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphomaPeter Hillmen, Jennifer R Brown, Barbara F Eichhorst, et al.
Microbiology Spectrum|August 12, 2025
Clinical characteristics and efficacy of short-course antibiotic therapy for Staphylococcus aureus bacteremia in hematological patientsNuobing Yang, Hui Wang, Xiaomeng Feng, et al.
Biomarker Research|May 23, 2026
Single-cell transcriptomic mapping of immune heterogeneity across angioimmunoblastic T-cell lymphoma subtypesHuimin Liu, Yang Tong, Meijuan Wu, et al.
Cancer Letters|June 28, 2015
Anti-tumor activity of the proteasome inhibitor BSc2118 against human multiple myelomaMeirong Zang, Zengjun Li, Lanting Liu, et al.
Leukemia & Lymphoma|July 12, 2022
The clinical characteristics and prognosis of patients with primary plasma cell leukemia (pPCL) according to the new IMWG definition criteriaWenqiang Yan, Huishou Fan, Jingyu Xu, et al.
BMC Medical Genetics|February 18, 2017
BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phaseDehui Zou, Shuhua Yi, Rui Cui, et al.
Biology Open|June 26, 2020
STAT3 modulates reprogramming efficiency of human somatic cells; insights from autosomal dominant Hyper IgE syndrome caused by STAT3 mutationsZhen Yu, Natalia I Dmitrieva, Avram D Walts, et al.
Cancer|October 17, 2023
Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myelomaWenqiang Yan, Jingyu Xu, Huishou Fan, et al.
Pageof 26